Home / Investment Partners / Parkwalk Advisors

Parkwalk New2About Parkwalk Advisors

Parkwalk manage a series of EIS Funds that invest in innovative, high-growth university spinouts with strong IP backing their commercialisation. In 2017 Parkwalk joined forces with IP Group plc, a leading intellectual property commercialisation company that is listed on the Main Market of the London Stock Exchange under the ticker symbol IPO. As at 16 December 2024 combined group has net assets of £1.2bn. Parkwalk is the UK’s most active investor in the university spinout sector, and currently has over £500m of assets under management. 

arkwalk invests in UK technology companies that have IP backing and freedom to operate, generally spun-out of UK universities. Their funds seek to generate capital gains for investors, enhanced by the attractive tax relief provided by EIS. Parkwalk entered this investment sector in 2009, anticipating a wave of tax-efficient incentives launched by the UK government to stimulate innovative emerging technology companies and thereby help drive economic growth.

Parkwalk utilises academic, technology transfer, venture capital and personal networks developed over many years to gain access to the highest calibre deal-flow.

Why Choose Parkwalk?

Parkwalk EIS Funds have invested in over 180 companies, which have raised in excess of £2.5bn of funding between them since 2010 and over 2000 patents protect their technology and processes. The fund has had a strong track record and has returned over £150m cash back to investors. Parkwalk are one of the only EIS funds to publish their performance monthly on their website, available here: http://parkwalkadvisors.com/pw_performance/

Parkwalk has won 20+ awards, including from: Investment Week, the EIS Association and the Growth Investor Awards. Most recently, the team were awarded ‘Growth Investor of the Year 2024’ and ‘Best EIS Investment Manager’ for two consecutive years at the Growth Investor Awards in 2023 and 2022.

Parkwalk also manage a series of earlier-stage EIS Funds in conjunction with some of the world’s most highly regarded research institutes, including the University of Cambridge Enterprise Funds, the University of Oxford Innovation Funds, and the University of Bristol Enterprise Funds; these funds allow our investors access to some of the world’s highest calibre discoveries and IP.